BioCorRx Inc. (BICX)

BioCorRx Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-3.77	-4.37	-5.8	-4.01	-7.71
Depreciation & Amortization	0.2	0.14	0.17	0.17	0.1
Share-Based Compensation	0.28	0.35	0.21	0.36	1.97
Other Operating Activities	1.44	1.83	1.89	1.34	2.71
Operating Cash Flow	-1.85	-2.04	-3.54	-2.15	-2.94
Capital Expenditures	0	0	-0.05	-0.01	-0.12
Acquisitions	0	0	0	0	0
Investing Cash Flow	0	0	-0.05	-0.01	-0.12
Common Stock Issued	0.92	1.25	2.25	0	0.1
Other Financing Activities	0.93	0.77	0.83	0.11	5.33
Financing Cash Flow	1.85	2.02	3.08	0.11	5.43
Net Cash Flow	-0	-0.02	-0.51	-2.05	2.37
Free Cash Flow	-1.85	-2.04	-3.59	-2.16	-3.06
Free Cash Flow Margin	-2078.60%	-954.81%	-7432.17%	-1762.42%	-1273.51%
Free Cash Flow Per Share	-0.22	-0.28	-0.55	-0.40	-0.87

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.